Termination of Pregnancy
12
0
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide
Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :
Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy
NAVIGATION ASSISTED CARE PROGRAM AND TERMINATION OF PREGNANCY
Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia
A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital
Ulipristal Acetate for Cervical Preparation
Multi-Media E-Book for Second-Trimester Termination Due to Fetal Anomaly
Obstetric & Pediatric Evolution Following Parental Refusal for Early Termination of Pregnancy Despite Fetal Risk
TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion